randomized Phase 2b

Related by string. * randomizing . randomizer . Randomized : randomized controlled trial . randomized controlled trials . randomized placebo controlled . randomized clinical trials / phases . Phases . phase . PHASE : Phase III clinical trials . Phase III trials . Phase III clinical . pivotal Phase III / 2Bs . 2BD . 2B : 2B Marcus Giles . Phase 2b clinical . 2B Luis Castillo . 2B Freddy Sanchez * *

Related by context. Frequent words. (Click for all words.) 70 phase IIa 70 phase IIb 68 Phase Ib 67 Phase Ia 67 Phase 2b study 67 Phase 2a clinical 67 randomized Phase 67 randomized Phase III 66 Phase 1b 66 Phase 2a trial 65 Phase 2b clinical 65 axitinib 65 Phase 1b trial 65 Phase 2b trial 65 confirmatory Phase III 65 phase 2a 65 Phase 2b 65 sapacitabine 65 Phase IIb 65 tesmilifene 65 Phase IIb clinical 65 Phase 1b clinical 64 Phase IIa clinical 64 Phase 1a 63 HGS ETR1 63 PXD# 63 Phase 2a 63 dose escalation trial 63 Phase IIa trial 63 multicenter clinical 63 placebo controlled randomized 62 multicenter randomized double 62 MOZOBIL 62 ZYBRESTAT 62 Phase III 62 pivotal Phase 62 Phase III randomized 61 dose escalation 61 multiple ascending dose 61 subgroup analyzes 61 pivotal Phase III 61 PROPEL trial 61 Phase IIb trial 61 confirmatory Phase 3 61 dose cohorts 61 Phase IIa 61 Secondary endpoints 61 pharmacokinetic studies 61 TELCYTA 61 blinatumomab 61 evaluable patients 61 Phase III clinical 60 unblinded 60 Phase II 60 teduglutide 60 pralatrexate 59 Phase III pivotal 59 belinostat 59 CA4P 59 ASA# 59 plus prednisone 59 HuMax CD# 59 decitabine 59 SCH # 59 relapsed multiple myeloma 59 methylnaltrexone 59 talactoferrin 59 DSMB 59 imetelstat 59 palifosfamide 59 vandetanib 59 CoFactor 59 Pharmacokinetic 59 voreloxin 59 nitazoxanide 58 single ascending dose 58 PROPEL 58 TOCOSOL Paclitaxel 58 vicriviroc 58 ECOG 58 randomized controlled clinical 58 PROMACTA 58 FOLOTYN 58 DR Cysteamine 58 maribavir 58 refractory multiple myeloma 58 ridaforolimus 58 Phase IIa clinical trials 58 multicenter 58 active comparator 58 efficacy endpoints 58 GVAX 58 ISIS # 58 Chrysalin 58 MGCD# [001] 57 SPIRIT III 57 BCX# 57 picoplatin 57 tolerated dose MTD 57 AP# [003] 57 XL# [003]

Back to home page